A new drug that prevents pancreatic cancer from becoming treatment-resistant may be a breakthrough in the fight against the deadly disease.
Pancreatic cancer is the third deadliest type of cancer because the disease is usually diagnosed too late and often chemotherapy stops having an affect on the tumors.
Cracking the code to these two problems might finally give sufferers a shot at more than five years of life after diagnosis.
A new drug developed by Cedars-Sinai Medical Center researchers could keep pancreatic cancer vulnerable and bolster other treatment drugs, raising survival rates by as much as 50 percent, early tests in mice suggest. MORE